MedTrace Logo

Cooperative Huntington's Observational Research Trial

NCT00313495 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2011-03-07

No results posted yet for this study

Summary

The purpose of this study is to collect prospective data from individuals who are part of a Huntington Disease (HD) family, in order to relate phenotypes between individuals and families with each other and genetic factors in order to learn more about HD, develop potential treatments for HD, and to plan for future research studies of experimental drugs aimed at slowing or postponing the onset and progression of HD.

Conditions

  • Huntington Disease

Sponsors & Collaborators

  • Huntington Study Group

    collaborator NETWORK

  • HP Therapeutics Foundation

    lead OTHER

Principal Investigators

  • Ira Shoulson, MD · University of Rochester/Huntington Study Group

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States
  • Australia
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313495 on ClinicalTrials.gov